| |
| |
|
| Insider
Information: |
Kozin Marc D |
| Relationship: |
Director |
| City: |
Boston |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
40,195 |
|
|
Indirect Shares
|
39,000 |
|
|
| Direct
Value |
$7,066,497 |
|
|
|
Indirect Value
|
$6,084 |
|
|
| Total
Shares |
79,195 |
|
|
| Total
Value |
$7,072,581 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
2
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
1
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
0.0
|
| Percentage
Gain/Loss : |
 -100.0%
|
 41.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
UFP Technologies Inc |
UFPT |
Director |
2023-06-07 |
27,955 |
2010-11-18 |
0 |
Premium* |
|
|
Tempest Therapeutics, Inc |
TPST |
Director |
2018-12-07 |
7,740 |
|
0 |
Premium* |
|
|
Endocyte Inc |
ECYT |
Director |
2018-12-21 |
0 |
2015-05-14 |
0 |
Premium* |
|
|
Salarius Pharmaceuticals, Inc |
SLRX |
Director |
2015-11-19 |
4,500 |
2015-11-19 |
0 |
Premium* |
|
|
Isleworth Healthcare Acquisition... |
ISLE |
Director |
2021-09-08 |
0 |
|
0 |
Premium* |
|
|
Dicerna Pharmaceuticals Inc |
DRNA |
Director |
2021-12-28 |
0 |
2021-12-28 |
0 |
Premium* |
|
|
Notable Labs |
NTBL |
Director |
|
0 |
2023-01-01 |
39,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
57 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TPST |
Tempest Therapeutics, Inc |
Director |
– • – |
2017-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
6,477 |
43,764 |
0 |
- |
|
| TPST |
Tempest Therapeutics, Inc |
Director |
– • – |
2017-09-29 |
4 |
A |
$0.00 |
$0 |
D/D |
8,230 |
51,994 |
0 |
- |
|
| TPST |
Tempest Therapeutics, Inc |
Director |
– • – |
2017-12-29 |
4 |
A |
$0.00 |
$0 |
D/D |
8,348 |
60,342 |
0 |
- |
|
| TPST |
Tempest Therapeutics, Inc |
Director |
– • – |
2018-03-30 |
4 |
A |
$0.00 |
$0 |
D/D |
14,411 |
74,753 |
0 |
- |
|
| ECYT |
Endocyte Inc |
Director |
– • – |
2018-05-03 |
4 |
A |
$0.00 |
$0 |
D/D |
3,300 |
11,100 |
0 |
- |
|
| UFPT |
UFP Technologies Inc |
Director |
– • – |
2018-05-14 |
4 |
OE |
$10.14 |
$77,978 |
D/D |
7,115 |
27,836 |
0 |
- |
|
| UFPT |
UFP Technologies Inc |
Director |
– • – |
2018-06-06 |
4 |
A |
$0.00 |
$0 |
D/D |
561 |
28,397 |
0 |
- |
|
| TPST |
Tempest Therapeutics, Inc |
Director |
– • – |
2018-06-29 |
4 |
A |
$0.00 |
$0 |
D/D |
12,880 |
87,633 |
0 |
- |
|
| TPST |
Tempest Therapeutics, Inc |
Director |
– • – |
2018-09-28 |
4 |
A |
$0.00 |
$0 |
D/D |
16,014 |
103,647 |
0 |
- |
|
| TPST |
Tempest Therapeutics, Inc |
Director |
– • – |
2018-12-07 |
4 |
A |
$0.00 |
$0 |
D/D |
831 |
7,740 |
0 |
- |
|
| ECYT |
Endocyte Inc |
Director |
– • – |
2018-12-21 |
4 |
D |
$24.00 |
$266,400 |
D/D |
(11,100) |
0 |
0 |
- |
|
| UFPT |
UFP Technologies Inc |
Director |
– • – |
2019-06-05 |
4 |
A |
$0.00 |
$0 |
D/D |
907 |
29,304 |
0 |
- |
|
| UFPT |
UFP Technologies Inc |
Director |
– • – |
2019-09-05 |
4 |
OE |
$9.09 |
$58,800 |
D/D |
6,407 |
35,711 |
0 |
- |
|
| UFPT |
UFP Technologies Inc |
Director |
– • – |
2019-09-10 |
4 |
S |
$39.50 |
$104,202 |
D/D |
(2,610) |
33,101 |
0 |
- |
|
| UFPT |
UFP Technologies Inc |
Director |
– • – |
2019-09-11 |
4 |
S |
$39.90 |
$151,569 |
D/D |
(3,797) |
29,304 |
0 |
- |
|
| UFPT |
UFP Technologies Inc |
Director |
– • – |
2020-03-06 |
4 |
OE |
$16.17 |
$360,908 |
D/D |
16,233 |
45,537 |
0 |
- |
|
| UFPT |
UFP Technologies Inc |
Director |
– • – |
2020-03-10 |
4 |
S |
$44.84 |
$227,224 |
D/D |
(4,933) |
40,604 |
0 |
% |
|
| UFPT |
UFP Technologies Inc |
Director |
– • – |
2020-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
796 |
41,400 |
0 |
- |
|
| UFPT |
UFP Technologies Inc |
Director |
– • – |
2021-03-08 |
4 |
GD |
$0.00 |
$0 |
D/D |
4,000 |
27,400 |
0 |
- |
|
| UFPT |
UFP Technologies Inc |
Director |
– • – |
2021-03-08 |
4 |
S |
$50.66 |
$540,957 |
D/D |
(10,000) |
31,400 |
0 |
% |
|
| DRNA |
Dicerna Pharmaceuticals I... |
Director |
– • – |
2021-06-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,333 |
3,333 |
0 |
- |
|
| UFPT |
UFP Technologies Inc |
Director |
– • – |
2021-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
610 |
28,010 |
0 |
- |
|
| DRNA |
Dicerna Pharmaceuticals I... |
Director |
– • – |
2021-08-10 |
4 |
B |
$23.66 |
$70,986 |
D/D |
3,000 |
6,333 |
2.39 |
% |
|
| ISLE |
Isleworth Healthcare Acqu... |
Director |
– • – |
2021-09-08 |
4 |
D |
$0.00 |
$0 |
D/D |
(36,000) |
0 |
0 |
- |
|
| DRNA |
Dicerna Pharmaceuticals I... |
Director |
– • – |
2021-12-28 |
4 |
D |
$38.25 |
$242,237 |
D/D |
(6,333) |
0 |
0 |
- |
|
57 Records found
|
|
Page 2 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
